HIV

GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors
Fierce Pharma
Wed, 10/9/19 - 09:49 am
GSK
ViiV Healthcare
Dovato
DTC ads
HIV
Johnson & Johnson commits $500 million over four years to help end HIV, TB epidemics
Marketwatch
Fri, 10/4/19 - 10:29 am
JNJ
Janssen
tuberculosis
HIV
philanthropy
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Thu, 10/3/19 - 10:21 pm
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
Wed, 09/25/19 - 09:16 am
GSK
ViiV
Tivicay
HIV
HemoShear
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
Fri, 09/20/19 - 09:44 am
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
HIV-focused Gilead launches fund, pledges $2M to help transgender people
Fierce Pharma
Thu, 09/12/19 - 10:34 pm
Gilead Sciences
HIV
transgender
philanthropy
CRISPR Gene-Editing May Offer Path To Cure For HIV, First Published Report Shows
NPR
Wed, 09/11/19 - 11:42 pm
HIV
CRISPR
gene editing
GSK's ViiV reports positive data for long-acting two-drug HIV therapy
Biopharma Dive
Thu, 08/22/19 - 11:46 am
ViiV Healthcare
GSK
HIV
cabotegravir
rilpivirine
Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Forbes
Mon, 08/12/19 - 10:28 am
HIV
Public Health
antiretrovirals
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Fri, 08/9/19 - 07:42 pm
Roche
viral assays
HIV
HPV
diagnostics
Global Access Program
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
Thu, 08/8/19 - 12:56 pm
FDA
Gilead Sciences
HIV
Descovy
PrEP
Regulators, Gilead at odds over HIV drug's use in women
Biopharma Dive
Mon, 08/5/19 - 10:31 pm
Gilead Sciences
HIV
Descovy
ViiV’s first-in-class HIV drug on course for filings this year
Pharmaforum
Tue, 07/23/19 - 10:16 am
ViiV Healthcare
HIV
fostemsavir
FDA
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Mon, 07/22/19 - 10:08 am
Gilead Sciences
Durect
HIV
hepatitis B
extended release
J&J gears up for clinical test of HIV vaccine efficacy
Fierce Biotech
Mon, 07/15/19 - 10:06 am
JNJ
clinical trials
HIV
vaccines
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
Sat, 07/13/19 - 11:34 am
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
Scripps Research Snags $129 Million for HIV Vaccine Investigation
BioSpace
Thu, 07/11/19 - 11:01 pm
Scripps Research Institute
HIV
vaccines
ViiV's HIV Drug Hits Endpoints in Late-Stage Comparison Trial
BioSpace
Wed, 07/10/19 - 10:18 am
GSK
ViiV Healthcare
Dovato
HIV
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
BioSpace
Tue, 07/9/19 - 06:44 pm
Gilead Sciences
Lyndra Therapeutics
HIV
ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment
Pharmaceutical Business Review
Tue, 07/9/19 - 08:51 am
ViiV Healthcare
HIV
cabotegravir
rilpivirine

Pages